[PDF] tandfonline.com

[PDF][PDF] RETRACTED ARTICLE: Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

G Yu, Z Ali, A Sajjad Khan, K Ullah… - International Journal …, 2021 - Taylor & Francis
Yu G, Ali Z, Sajjad Khan A, et al. Int J Nanomedicine. 2021; 16: 3255-3273. At the authors
request, the Editor and Publisher of International Journal of Nanomedicine wish to retract the …
被引用次数：42 相关文章

Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

G Yu, Z Ali, AS Khan, K Ullah… - INTERNATIONAL …, 2021 - repository.hanyang.ac.kr
Background The purpose of this study was to investigate the suitability of nanostructured
lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment …

RETRACTED ARTICLE: Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

G Yu, Z Ali, AS Khan, K Ullah, H Jamshaid… - International Journal …, 2021 - dovepress.com
Background: The purpose of this study was to investigate the suitability of nanostructured
lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment …
[PDF] scienceopen.com

[PDF][PDF] Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

G Yu, Z Ali, AS Khan, K Ullah, H Jamshaid… - International Journal …, 2021 - scienceopen.com
Background: The purpose of this study was to investigate the suitability of nanostructured
lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment …

Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers (Retracted article. See vol. 18, pg. 1107, 2023)

G Yu, Z Ali, AS Khan, K Ullah… - International journal …, 2021 - scholarworks.bwise.kr
Background: The purpose of this study was to investigate the suitability of nanostructured
lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment …
[PDF] semanticscholar.org

[PDF][PDF] Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

G Yu, Z Ali, AS Khan, K Ullah… - International …, 2021 - pdfs.semanticscholar.org
Background: The purpose of this study was to investigate the suitability of nanostructured
lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment …

Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers.

G Yu, Z Ali, AS Khan, K Ullah, H Jamshaid… - International Journal of …, 2021 - go.gale.com
Background: The purpose of this study was to investigate the suitability of nanostructured
lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment …

Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

G Yu, Z Ali, AS Khan, K Ullah… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The purpose of this study was to investigate the suitability of nanostructured
lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment …
[PDF] academia.edu

[PDF][PDF] Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

G Yu, Z Ali, AS Khan, K Ullah, H Jamshaid… - International Journal of …, 2021 - academia.edu
Background: The purpose of this study was to investigate the suitability of nanostructured
lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment …
[HTML] nih.gov

[HTML][HTML] Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

G Yu, Z Ali, AS Khan, K Ullah, H Jamshaid… - International Journal …, 2021 - ncbi.nlm.nih.gov
Background The purpose of this study was to investigate the suitability of nanostructured
lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment …